Splenectomy incidence in a specialized care hospital
Main Article Content
Keywords
Splenectomy, Hematologic Diseases, Thrombocytopenic Purpura
Abstract
Background: splenectomy has been elected surgical procedure for multiple hematologic diseases, specially for Idiopathic Thrombocytopenic Purpura. The aim of this study was to compare the incidence of splenectomies in two different periods of time and to show decrease tendency during the most recent years.
Methods: it was a retrospectively reviewed study from medical records of patients who underwent splenectomy at the Hospital de Especialidades Siglo XXI, between 1986 to 1990 and 1995 to 1999.
Results: during the first period of time, the incidence of splenectomies for hospital admissions was 0.52 %, and in the second 0.19 %.
Conclusions: the incidence of splenectomies performed at the Hospital de Especialidades Siglo XXI decreased in the second period of time, probably because there are new available treatments for hematologic diseases.
References
Chadburn A. The spleen; anatomy and anatomical function. Semin Hematol 2000; 37:13-21.
Chapman WC, Newman M. Disordes of the spleen. En: Greer JP, Foerster J, Lukens JN, editors. Wintrobe’s clinical hematology. Tenth edition. Philadelphia, USA: Lea and Febiger; 1999.
Katkhouda N. Laparoscopic splenectomy. Surg Clin North Am 2000; 80:95-101.
Bell R. Long-term outcome of splenectomy for idiopathic thrombocytopenic purpura. Semin Hematol 2000; 38:22-25.
Rose A. The incidence of splenectomy is decressing: lessons learned for trauma experience. Am Surg 2000; 6:481-186.
Traetow K, Fabri P, Carey L. Changing indications for splenectomy: 30 years experience. Arch Surg 1980; 115:447-451.
Bussel J. Splenectomy-sparing strategies for the treatment and long-term maintenance of chronic idiopathic (immune) thrombocytopenic purpura. Semin Hematol 2000; 37:1-4.
Marble K. Changing role of splenectomy in hematologic disease. J Surg Oncol 1993; 52:169-171.
Schwartz S. Role of splenectomy in hematologic disorders. World J Surg 1996; 20:1156-1159.
Bennett C, Weinberg P, Golub R, Bushel J. The potencial for treatment of idiopathic thrombocytopenic purpura UIT anti-D to prevent splenectomy: a predictive cost-analysis. Semin Hematol 2000; 37:26-40.
George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996; 88:3-40.
Sackey K. Hemolytic anemia. Pediatr Rev 1999; 20:152-160.